Security key
87650L103
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 43,391,345
- Total 13F value
- $1,426,965,052
- Share change
- +2,835,764
- Put/Call ratio
- 0.85%
- SEC-reported price per share
- $32.89
- Number of holders
- 161
- Value change
- +$102,534,235
- Number of buys
- 95
- Number of sells
- 67
- Shares outstanding
- 43,212,246
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
161
Top holders
10
TARS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Tarsus Pharmaceuticals, Inc. SEC filings
Tarsus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87650L103
Recent filing periods:
Ownership snapshot
Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
3/4/5
Highest disclosed value: $92,751,369
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP has the largest disclosed position value at $92.75M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Disclosed position value
Top 5
RTW INVESTMENTS, LP
$92.75M
Vivo Capital IX, LLC
$49.38M
Jason E. Tester
$109.9K
BlackRock Finance, Inc.
$88.79M
Paradigm Biocapital Advisors LP
$66.19M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$92,751,369
3,412,486 shares
|
— | 30 Jun 2024 |
| Vivo Capital IX, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$49,380,020
2,469,001 shares
|
— | 05 May 2022 |
| Jason E. Tester |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
$109,900
10,000 shares
|
— | 15 Jun 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$88,789,285
3,266,714 shares
|
— | 30 Jun 2024 |
| Paradigm Biocapital Advisors LP |
13F
Company
|
—
denominator unverified
|
$66,194,607
2,435,416 shares
|
— | 30 Jun 2024 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$61,285,382
2,254,797 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
161
Shares
43,391,345
Rows available
161
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
147
Q3 2024 holders
161
Holder diff
14
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend